# Teleflex to buy Biotronik's vascular intervention catalog for €760M

Teleflex agreed to buy substantially all of Biotronik's vascular intervention catalog for about €760 million ($791 million), including drug-coated balloons, stents, and the PK Papyrus rescue stent. The deal is expected to close by the end of Q3 2025.

- Type: Acquisition
- Announced: 2025-02-27
- Where: Germany
- Value: $791.0M (760.0M EUR)
- Status: announced
- Products: drug-coated balloons, stents, PK Papyrus covered rescue stent
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Teleflex](https://endata.com/companies/20113.md) (acquirer)
- [Biotronik AB](https://endata.com/companies/32223.md) (target)

## Sources

- [fiercebiotech.com](https://www.fiercebiotech.com/medtech/teleflex-plays-musical-chairs-plans-company-split-amid-eu760m-biotronik-cardiovascular-deal), 2025-02-27: "We believe the acquisition will allow us to position this advanced coronary portfolio alongside our existing Interventional business and establish our global footprint in the fast-growing peripheral intervention market."
- [medicalbuyer.co.in](https://medicalbuyer.co.in/teleflex-to-acquire-biotroniks-vascular-intervention-biz/), 2025-03-03: "We believe the acquisition will allow us to position this advanced coronary portfolio alongside our existing interventional business and establish our global footprint in the fast-growing peripheral intervention market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.